Global Microbiology Testing/Clinical Microbiology Device Market – Industry analysis and forecast (2019 to 2026) – By Product, Disease Area, End User and Region.

Global Microbiology Testing/Clinical Microbiology Devices Market was valued at USD3.45 billion in 2019 and is estimated to grow at a CAGR of XX % from 2019 to 2026. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. The Clinical Microbiology testing plays an important role in the diagnosis and management of patients with less respiratory tract infections. By providing diagnostic recognition, understanding and examining the sensitivity of the lab, it provides support for good genetic antiseptic treatment and individually adjusting regulation. Increasing levels of air pollution with growing industrialization, a prevalence of respiratory diseases, and ongoing technological advancements in the field of infectious disease diagnosis are certain key factors boosting the overall growth of the Global Microbiology Testing/Clinical Microbiology Devices Market. Moreover, rising incidence of infectious diseases, growing outbreak of epidemics, together with increased funding and public-private investments for research and innovation have further boosted the overall market growth for Global Microbiology Testing/Clinical Microbiology Devices Market. Global Microbiology Testing/Clinical Microbiology Devices Market is segmented by product, disease area, end user, and region. The molecular diagnostic instruments segment is expected to exhibit the most expeditious magnification rate over the forecast period. This magnification can be attributed to incrementing paramount of molecular diagnosis in early detection of cancer and infectious diseases. The global microbiology testing device has the largest usage in hospitals, diagnostic centers, custom lab service providers, academic and research. As the regions are taken into consideration, Asia Pacific is expected to grow at the fastest rate during the forecast period. The rising number of hospitals and clinical diagnostic laboratories in emergent APAC countries such as China and India, intensifying research capabilities for the development of innovative and affordable clinical microbiology testing procedures and the rise in the occurrence of contagious diseases are certain key drivers that have boosted the growth of Global Microbiology Testing/Clinical Microbiology Devices Market. The major players in the Global Microbiology Testing/Clinical Microbiology Devices Market are bioMérieux SA (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche AG (Switzerland), Bruker Corporation (US), Hologic, Inc. (US), Qiagen N.V. (The Netherlands), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Shimadzu Corporation (Japan), 3M Company (US), and Neogen Corporation (US), Alere, The Water Treatment Products Company, VWR International, LLC, TSI and Cepheid The objective of the report is to present comprehensive Global Microbiology Testing Clinical Microbiology Device Market  including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Microbiology Testing Clinical Microbiology Device Market  North America for Asia Pacific dynamics, structure by analyzing the market segments, and project the Global Microbiology Testing Clinical Microbiology Device Market  North America for Asia Pacific   size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Microbiology Testing Clinical Microbiology Device Market  North America for Asia Pacific make the report investor’s guide.

Global Microbiology Testing/Clinical Microbiology Device Market - key Segment

Global Microbiology Testing/Clinical Microbiology Device Market, By Products

• Instruments o Laboratory Instruments  Incubators  Gram Strainers  Bacterial Colony Counters  Autoclave Sterilizers  Microbial Air Samplers  Anaerobic Culture Systems  Petri Dish Fillers  Blood Culture Systems  Microbial Culture Systems  Other Laboratory Instruments o Microbiology Analysers  Molecular Diagnostic Instruments  Microscopes  Mass Spectrometers • Reagents o Pathogen-Specific Kits o General Reagents

Global Microbiology Testing/Clinical Microbiology Device Market, By Disease Area

• Respiratory Diseases • Bloodstream Infections • Gastrointestinal Diseases • Sexually Transmitted Diseases • Urinary Tract Infections (UTIs) • Periodontal Diseases • Other Diseases

Global Microbiology Testing/Clinical Microbiology Device Market, By End User

• Hospitals and Diagnostic centers • Custom Lab Service Providers • Academic and Research Institutes

Global Microbiology Testing/Clinical Microbiology Device Market, By Region

North America • U.S • Canada Europe • Germany • France • UK • Italy • Spain • Russia • Rest of Europe Asia Pacific • Japan • China • India • South Korea • Australia • Rest of Asia Pacific Rest of the World (ROW): • Middle-East • Africa • Latin America Research Methodology: The market is estimated by analyzing the data points obtained from various sources and conducting them into a predictor model created specifically for each individual market. The data points are extracted from paid and unpaid sources along with paid primary interviews with key opinion leaders in the market. Key opinion leaders from both demand and supply sides of the market were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this analysis. This country-specific analysis was accumulated to establish regional numbers and then arrive at the global market value for Global Microbiology Testing/Clinical Microbiology Device Market.

Global Microbiology Testing/Clinical Microbiology Device Market

1. INTRODUCTION 1.1. Market description & Scope (2019-2026) 1.2. Objectives 1.2.1. Key Takeaways 1.2.2. Abbreviations & Acronyms 2. RESEARCH METHODOLOGY 2.1. Methods used for market forecasting 2.2. Data Sources 2.2.1. Paid Databases 2.2.2. Primary Sources 2.2.3. Secondary Sources 3. EXECUTIVE SUMMARY 3.1. Major Findings 3.1.1. Key Segment Trends 3.1.1.1. Product 3.1.1.2. Disease Area 3.1.1.3. End-user 3.1.2. Key Regional Trends 3.1.2.1. North America 3.1.2.2. Europe 3.1.2.3. Asia Pacific 3.1.2.4. Middle-East 3.1.2.5. Latin America 3.2. Key Companies and their Strategies 4. MARKET OVERVIEW 4.1. Microbiology Testing Concept & Definition 4.2. Segments Overview 4.2.1. By Product 4.2.1.1. Instruments 4.2.1.1.1. Laboratory Instruments 4.2.1.1.1.1. Incubators 4.2.1.1.1.2. Gram Strainers 4.2.1.1.1.3. Bacterial Colony Counters 4.2.1.1.1.4. Autoclave Sterilizers 4.2.1.1.1.5. Microbial Air Samplers 4.2.1.1.1.6. Anaerobic Culture Systems 4.2.1.1.1.7. Petri Dish Fillers 4.2.1.1.1.8. Blood Culture Systems 4.2.1.1.1.9. Microbial Culture Systems 4.2.1.1.1.10. Other Laboratory Instruments 4.2.1.1.2. Microbiology Analysers 4.2.1.1.2.1. Molecular Diagnostic Instruments 4.2.1.1.2.2. Microscopes 4.2.1.1.2.3. Mass Spectrometers 4.2.1.2. Reagents 4.2.1.2.1. Pathogen-Specific Kits 4.2.1.2.2. General Reagents 4.2.2. By Disease Area 4.2.2.1. Respiratory Diseases 4.2.2.2. Bloodstream Infections 4.2.2.3. Gastrointestinal Diseases 4.2.2.4. Sexually Transmitted Diseases 4.2.2.5. Urinary Tract Infections (UTIs) 4.2.2.6. Periodontal Diseases 4.2.2.7. Other Diseases 4.2.3. By End-user 4.2.3.1. Hospitals and Diagnostic centers 4.2.3.2. Custom Lab Service Providers 4.2.3.3. Academic and Research Institutes 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Porter’s Analysis 4.5. PESTLE Analysis 4.6. Fragmentation 4.6.1. Key strategic Alliances of companies (inorganic & organic) 4.6.2. Company Market Share (Top 10 Players) 4.6.3. Comparative Analysis of Key players in Microbiology Testing 4.7. Key Trends 4.8. Key Trends in Global Microbiology Testing/Clinical Microbiology Device Market 5. GLOBAL MICROBIOLOGY TESTING PRODUCT ESTIMATES & TREND ANALYSIS (2019-2026) 5.1. Global Microbiology Testing Market: Product Analysis 5.1.1. Instruments 5.1.1.1. Market Share and growth forecasts, 2019-2026(USD Billion) 5.1.2. Reagents 5.1.2.1. Market Share and growth forecasts, 2019-2026(USD Billion) 5.2. Global Microbiology Testing Market: Product Trends 6. GLOBAL MICROBIOLOGY TESTING DISEASE AREA ESTIMATES & TREND ANALYSIS (2019-2026) 6.1. Global Microbiology Testing Market: Disease Area Analysis 6.1.1. Respiratory Diseases 6.1.1.1. Market Share and growth forecasts,2019-2026(USD Billion) 6.1.2. Bloodstream Infections 6.1.2.1. Market Share and growth forecasts, 2019-2026(USD Billion) 6.1.3. Gastrointestinal Diseases 6.1.3.1. Market Share and growth forecasts,2019-2026(USD Billion) 6.1.4. Sexually Transmitted Diseases 6.1.4.1. Market Share and growth forecasts, 2019-2026(USD Billion) 6.1.5. Urinary Tract Infections (UTIs) 6.1.5.1. Market Share and growth forecasts,2019-2026(USD Billion) 6.1.6. Periodontal Diseases 6.1.6.1. Market Share and growth forecasts,2019-2026(USD Billion) 6.1.7. Others 6.1.7.1. Market Share and growth forecasts,2019-2026(USD Billion) 6.2. Global Microbiology Testing Market: Disease Area Trends 7. GLOBAL MICROBIOLOGY TESTING END-USER ESTIMATES & TREND ANALYSIS (2019-2026) 7.1. Global Microbiology Testing Market: End-user Analysis 7.1.1. Hospitals and Diagnostic Centers 7.1.1.1. Market Share and growth forecasts,2019-2026(USD Billion) 7.1.2. Custom Lab Service Providers 7.1.2.1. Market Share and growth forecasts, 2019-2026(USD Billion) 7.1.3. Academic and Research Institutes 7.1.3.1. Market Share and growth forecasts, 2019-2026(USD Billion) 7.2. Global Microbiology Testing Market: End-user Trends 8. REGIONAL ESTIMATES & TREND ANALYSIS (2019-2026) 8.1. Global Microbiology Testing market share by Region, 2016 & 2025 8.2. North America 8.2.1. North America Microbiology Testing market, Market Share and growth forecasts, 2019-2026(USD Billion) 8.2.2. Microbiology Testing Drivers For North America Market 8.2.3. Market Share Analysis and Growth Forecast, by Country 8.2.3.1. US 8.2.3.2. Canada 8.2.4. Country-wise GDP Growth Forecast 8.2.5. Microbiology Testing Trends In North America Market 8.3. Europe 8.3.1. Europe Microbiology Testing market, Market Share and growth forecasts, 2019-2026(USD Billion) 8.3.2. Microbiology Testing Drivers For Europe Market 8.3.3. Market Share Analysis and Growth Forecast, by Country 8.3.3.1. UK 8.3.3.2. Germany 8.3.3.3. France 8.3.3.4. Russia 8.3.3.5. Spain 8.3.3.6. Italy 8.3.3.7. Others 8.3.4. Country-wise GDP Growth Forecast 8.3.5. Microbiology Testing Trends In Europe Market 8.4. Asia Pacific 8.4.1. Asia Pacific Microbiology Testing market, Market Share and growth forecasts, 2019-2026(USD Billion) 8.4.2. Microbiology Testing Drivers For Asia Pacific Market 8.4.3. Market Share Analysis and Growth Forecast, by Country 8.4.3.1. China 8.4.3.2. Japan 8.4.3.3. India 8.4.3.4. South Korea 8.4.3.5. Australia 8.4.3.6. Others 8.4.4. Country-wise GDP Growth Forecast 8.4.5. Microbiology Testing Trends In Asia Pacific Market 8.5. Middle-east 8.5.1. Middle-east Microbiology Testing market, Market Share and growth forecasts, 2019-2026(USD Billion) 8.5.2. Microbiology Testing Drivers For Middle-east Market 8.5.3. Market Share Analysis and Growth Forecast, by Country 8.5.3.1. GCC Countries 8.5.3.2. Saudi Arabia 8.5.4. Country-wise GDP Growth Forecast 8.5.5. Microbiology Testing Trends In Middle-east Market 8.6. Latin America 8.6.1. Latin America Microbiology Testing market, Market Share and growth forecasts, 2019-2026(USD Billion) 8.6.2. Microbiology Testing Drivers For Latin America Market 8.6.3. Market Share Analysis and Growth Forecast, by Country 8.6.3.1. Brazil 8.6.3.2. Mexico 8.6.3.3. Others 8.6.4. Country-wise GDP Growth Forecast 8.6.5. Microbiology Testing Trends In Latin America Market 9. MARKET SHARE ANALYSIS 9.1. Key Players Regional Market share Analysis 9.1.1. North America 9.1.2. Europe 9.1.3. Asia Pacific 9.1.4. Middle-east 9.1.5. Latin America 10. MARKET COMPETITION ANALYSIS 10.1. Strategy Framework 10.2. Consolidation 10.2.1. Patent Analysis 10.2.2. Mergers & Acquisitions 10.2.2.1. Source Based 10.2.2.2. Services Based 10.2.2.3. Region Based 10.2.2.4. List of Mergers & Acquisitions 10.2.3. Company Benchmarking (Revenue & Profit Based) 10.2.4. Strategic Assessment of Company Consolidations 10.2.5. Emerging Business Models 10.3. Company Profiles 10.3.1. bioMérieux SA 10.3.1.1. Company overview 10.3.1.2. Key financials 10.3.1.3. Geographical presence 10.3.1.4. Source and Business Segments 10.3.1.5. Strategic initiatives 10.3.1.6. SWOT analysis 10.3.1.7. Competitive positioning and landscape 10.3.2. Danaher Corporation 10.3.2.1. Company overview 10.3.2.2. Key financials 10.3.2.3. Geographical presence 10.3.2.4. Source and Business Segments 10.3.2.5. Strategic initiatives 10.3.2.6. SWOT analysis 10.3.2.7. Competitive positioning and landscape 10.3.3. Becton, Dickinson and Company 10.3.3.1. Company overview 10.3.3.2. Key financials 10.3.3.3. Geographical presence 10.3.3.4. Source and Business Segments 10.3.3.5. Strategic initiatives 10.3.3.6. SWOT analysis 10.3.3.7. Competitive positioning and landscape 10.3.4. Abbott Laboratories 10.3.4.1. Company overview 10.3.4.2. Key financials 10.3.4.3. Geographical presence 10.3.4.4. Source and Business Segments 10.3.4.5. Strategic initiatives 10.3.4.6. SWOT analysis 10.3.4.7. Competitive positioning and landscape 10.3.5. Bio-Rad Laboratories, Inc. 10.3.5.1. Company overview 10.3.5.2. Key financials 10.3.5.3. Geographical presence 10.3.5.4. Source and Business Segments 10.3.5.5. Strategic initiatives 10.3.5.6. SWOT analysis 10.3.5.7. Competitive positioning and landscape 10.3.6. F. Hoffmann-La Roche AG 10.3.6.1. Company overview 10.3.6.2. Key financials 10.3.6.3. Geographical presence 10.3.6.4. Source and Business Segments 10.3.6.5. Strategic initiatives 10.3.6.6. SWOT analysis 10.3.6.7. Competitive positioning and landscape 10.3.7. Bruker Corporation 10.3.7.1. Company overview 10.3.7.2. Key financials 10.3.7.3. Geographical presence 10.3.7.4. Source and Business Segments 10.3.7.5. Strategic initiatives 10.3.7.6. SWOT analysis 10.3.7.7. Competitive positioning and landscape 10.3.8. Hologic, Inc. 10.3.8.1. Company overview 10.3.8.2. Key financials 10.3.8.3. Geographical presence 10.3.8.4. Source and Business Segments 10.3.8.5. Strategic initiatives 10.3.8.6. SWOT analysis 10.3.8.7. Competitive positioning and landscape 10.3.9. Qiagen N.V. 10.3.9.1. Company overview 10.3.9.2. Key financials 10.3.9.3. Geographical presence 10.3.9.4. Source and Business Segments 10.3.9.5. Strategic initiatives 10.3.9.6. SWOT analysis 10.3.9.7. Competitive positioning and landscape 10.3.10. Thermo Fisher Scientific Inc. 10.3.10.1. Company overview 10.3.10.2. Key financials 10.3.10.3. Geographical presence 10.3.10.4. Source and Business Segments 10.3.10.5. Strategic initiatives 10.3.10.6. SWOT analysis 10.3.10.7. Competitive positioning and landscape 10.3.11. Agilent Technologies, Inc. 10.3.11.1. Company overview 10.3.11.2. Key financials 10.3.11.3. Geographical presence 10.3.11.4. Source and Business Segments 10.3.11.5. Strategic initiatives 10.3.11.6. SWOT analysis 10.3.11.7. Competitive positioning and landscape 10.3.12. Merck KGaA 10.3.12.1. Company overview 10.3.12.2. Key financials 10.3.12.3. Geographical presence 10.3.12.4. Source and Business Segments 10.3.12.5. Strategic initiatives 10.3.12.6. SWOT analysis 10.3.12.7. Competitive positioning and landscape 10.3.13. Shimadzu Corporation 10.3.13.1. Company overview 10.3.13.2. Key financials 10.3.13.3. Geographical presence 10.3.13.4. Source and Business Segments 10.3.13.5. Strategic initiatives 10.3.13.6. SWOT analysis 10.3.13.7. Competitive positioning and landscape 10.3.14. 3M 10.3.14.1. Company overview 10.3.14.2. Key financials 10.3.14.3. Geographical presence 10.3.14.4. Source and Business Segments 10.3.14.5. Strategic initiatives 10.3.14.6. SWOT analysis 10.3.14.7. Competitive positioning and landscape 10.3.15. Neogen Corporation 10.3.15.1. Company overview 10.3.15.2. Key financials 10.3.15.3. Geographical presence 10.3.15.4. Source and Business Segments 10.3.15.5. Strategic initiatives 10.3.15.6. SWOT analysis 10.3.15.7. Competitive positioning and landscape 10.3.16. Alere 10.3.17. The Water Treatment Products Company 10.3.18. VWR International, LLC 10.3.19. TSI 10.3.20. Cepheid

About This Report

Report ID 10878
Category Healthcare
Published Date oct 2019
Updated Date oct 2020